Supplier · public contract awards

MSD Sharp & Dohme GmbH public contracts.

MSD Sharp & Dohme GmbH has won 160 public contracts between 2016 and 2026 from 20 public buyers in Germany. Its most frequent buyer is GWQ ServicePlus AG (27 awards). Outside TED, published values total €2.03 million across 10 awards. 82 awards were published on TED; the median contract size is about €210,000 (8 contracts with a value).

Start bidding All awards in Germany

160Contracts won

20Public buyers

1Country

Mar 2026Latest award

Latest contracts won

Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026

Awarded by Pbmg Eg · Germany

3 Mar 2026Awarded

Németország – Gyógyszerészeti termékek – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu dem Wirkstoff Ertugliflozin (

Awarded by GWQ ServicePlus AG · Germany

24 Dec 2025Awarded

Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025

Awarded by Pbmg Eg · Germany

5 May 2025Awarded

Németország – Gyógyszerészeti termékek – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025

Awarded by Pbmg Eg · Germany

15 Apr 2025Awarded

Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und der MSD Sharp & Dohme GmbH zu Steglatro (R)

Awarded by IKK classic · Germany

8 Mar 2023Awarded

Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Ertugliflozin (A10BK04) im Rahmen

Awarded by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Germany

8 Nov 2022Awarded

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination Sitagliptin + Metformin

Awarded by GWQ ServicePlus AG · Germany

10 Sep 2022Awarded

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Sitapliptin

Awarded by GWQ ServicePlus AG · Germany

10 Sep 2022Awarded

Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Sitagliptin (A10BH01) im Rahmen eines sogenannte

Awarded by AOK - Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Germany

8 Sep 2022Awarded

Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Metformin und Sitagliptin (A10BD07) im Rahmen ei

Awarded by AOK - Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Germany

8 Sep 2022Awarded

Contracts won by year

from the published records

20162

20184

20206

20212

202212

20232

20253

20261

Published value, by currency (feeds other than TED)

EUR · 10 valued

€2.03 million

Typical contract size on TED

EUR · median of 8 contracts

€210,000

From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted. TED values are often framework ceilings, so TED awards show a median contract size, never a total.

Bid with askTender

Bidding against MSD Sharp & Dohme GmbH?

askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.

Start bidding See open tenders